| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/11/2015 | CN103211799B 氟比洛芬对乙酰氨基酚酯外用缓释透皮贴剂及其制备方法 Flurbiprofen ester acetaminophen extended release transdermal patches and topical preparation |
| 02/11/2015 | CN103193820B 一种氮芥磷脂化合物及其制备方法 A phospholipid compounds and methods of mustard |
| 02/11/2015 | CN103153343B 具有提高的醋酸酯和琥珀酸酯取代的醋酸羟丙基甲基纤维素琥珀酸酯 Acetate and succinate substituted with improved hydroxypropylmethylcellulose acetate succinate |
| 02/11/2015 | CN103142608B 磷酸可待因和盐酸异丙嗪复方膜状制剂 Promethazine hydrochloride and codeine phosphate compound film preparation |
| 02/11/2015 | CN103120648B 一种异丙肌苷口服制剂及其制备方法 An oral preparation and preparation method inosine isopropyl |
| 02/11/2015 | CN103083683B 一种灯盏花素磷脂复合物及其制备方法和应用 One kind Breviscapine phospholipid complex and its preparation method and application |
| 02/11/2015 | CN103083259B 丹酚酸a冻干粉针用于制备挽救缺血半暗带药物的用途 Sal save a lyophilized powder for preparing the ischemic penumbra drug use |
| 02/11/2015 | CN103083258B 丹酚酸a冻干粉针用于制备保护脑血管内皮细胞药物的用途 Sal uses a freeze-dried powder for preparing protect the brain endothelial cells drugs |
| 02/11/2015 | CN103083256B 丹酚酸a冻干粉针用于制备预防和/或治疗脑血栓药物的用途 Sal a lyophilized powder for preparing the prevention and / or treatment of thrombosis drugs |
| 02/11/2015 | CN103083255B 丹酚酸a冻干粉针用于制备抑制脑组织神经元损伤或死亡药物的用途 Sal for the preparation of a freeze-dried powder inhibiting neuronal brain damage or death drugs |
| 02/11/2015 | CN102973569B 一种头孢米诺钠无菌混合粉形式的药物组合物 A Cefminox sodium mixed powder in the form of a sterile pharmaceutical composition |
| 02/11/2015 | CN102961417B 具有抗肺癌作用的中药多组分微乳组合物、其制备方法及其在制备口服抗肺癌药物中的应用 Multi-component microemulsion composition of traditional Chinese medicine with anti-cancer effects, their preparation and their use in the preparation of oral anti-cancer medicine |
| 02/11/2015 | CN102920663B 一种泛昔洛韦缓释微丸、其制备方法及应用 One kind of sustained-release pellets famciclovir, its preparation method and application |
| 02/11/2015 | CN102920662B 一种泛昔洛韦缓释微丸、其制备方法及应用 One kind of sustained-release pellets famciclovir, its preparation method and application |
| 02/11/2015 | CN102908550B 无糖型维c银翘颗粒及其制备方法 Sugar-dimensional c Yinqiao particle and its preparation method |
| 02/11/2015 | CN102895255B 一种单磷酸阿糖腺苷的药用组合物及其制备方法 A single-Ara-AMP pharmaceutical compositions and preparation method |
| 02/11/2015 | CN102885760B 氢溴酸加兰他敏缓释干混悬剂及其制备方法 Galantamine hydrobromide extended release dry suspension and its preparation method |
| 02/11/2015 | CN102869345B 用于治疗眼内压增高的药物组合物 For the treatment of elevated intraocular pressure pharmaceutical compositions |
| 02/11/2015 | CN102813651B 一种含埃索美拉唑钠的药物组合物及其制备方法 The pharmaceutical compositions containing esomeprazole sodium and its preparation method |
| 02/11/2015 | CN102802653B 植物锥形露兜树的脱色提取物 Cone pandanus plant extract bleaching |
| 02/11/2015 | CN102772365B 4-(4-(3-三氟甲基)苯甲酰胺基苯氧基)-2-(甲基氨甲酰基)吡啶纳米混悬剂及其制法和应用 4- (4- (3-trifluoromethyl) benzamido phenoxy) -2- (methylcarbamoyl) pyridin nanosuspension preparation method and application |
| 02/11/2015 | CN102770125B 钙泊三醇一水化合物纳米晶体 Calcipotriol monohydrate nanocrystals |
| 02/11/2015 | CN102755371B 用于辅助治疗断肢、指再植的中药 Medicine for the adjuvant treatment of limb, finger replantation |
| 02/11/2015 | CN102552888B 一种用于治疗哺乳动物子宫内膜炎的栓剂 An internal treating endometritis suppositories for |
| 02/11/2015 | CN102458366B 靶向pcsk9基因的脂质配制的dsrna Pcsk9 gene targeting lipid formulated dsrna |
| 02/11/2015 | CN102370902B 一种治疗肾病的药物及其制备方法 A treatment for kidney disease and its preparation method |
| 02/11/2015 | CN102335153B 一种阿魏酸哌嗪缓释片及其制备方法 One kind of ferulic acid piperazine sustained-release tablets and preparation method |
| 02/11/2015 | CN101340882B 含有药物的蜡基质粒子的制造方法、用于该方法的挤出机、及含有西洛他唑的缓释制剂 The method of producing drug-containing wax matrix particles, the method for the extruder, and comprising cilostazol sustained release preparations |
| 02/11/2015 | CN101056618B 眼用组合物和治疗眼睛的方法 Ophthalmic compositions and methods of treatment of the eye |
| 02/10/2015 | US8952164 R-7-(3-aminomethy-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydo-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial |
| 02/10/2015 | US8952150 Prostaglandin transporter inhibitors and uses thereof |
| 02/10/2015 | US8952106 Linear polyesteramides from aminophenolic esters |
| 02/10/2015 | US8952089 Systems and methods for providing a thermoplastic product that includes packaging therefor |
| 02/10/2015 | US8952075 Bioactive polymeric liquid formulations of absorbable, segmented aliphatic polyurethane compositions |
| 02/10/2015 | US8952074 Medicinal agent for treating patients suffering from diseases caused by the monoaminooxidase excessive activity and a method for treating patients suffering from diseases caused by the monoaminooxidase excessive activity |
| 02/10/2015 | US8952070 Antifungal composition |
| 02/10/2015 | US8952066 Pharmaceutical/cosmetic, E.G., anti-acne compositions comprising at least one naphthoic acid compound, benzoyl peroxide and at least one film-forming agent |
| 02/10/2015 | US8952065 Acetylcysteine composition and uses thereof |
| 02/10/2015 | US8952064 Pharmaceutical semi-solid composition of isotretinoin |
| 02/10/2015 | US8952062 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 02/10/2015 | US8952057 Compositions for anorectal use and methods for treating anorectal disorders |
| 02/10/2015 | US8952051 Ophthalmic formulations containing substituted gamma lactams and methods for use thereof |
| 02/10/2015 | US8952044 Antimycotic pharmaceutical composition |
| 02/10/2015 | US8952038 Inhibition of undesired sensory effects by the compound camphor |
| 02/10/2015 | US8952017 Acyclovir formulations |
| 02/10/2015 | US8952015 Inhibitors of Bruton's tyrosine kinase |
| 02/10/2015 | US8952013 Controlled release sterile injectable aripiprazole formulation and method |
| 02/10/2015 | US8952011 Compositions and methods for the treatment of nasal conditions |
| 02/10/2015 | US8951996 17-hydroxyprogesterone ester-containing oral compositions and related methods |
| 02/10/2015 | US8951974 Self-assembling peptide and peptide gel with high strength |
| 02/10/2015 | US8951973 Controlled-released peptide formulations |
| 02/10/2015 | US8951969 Compositions and methods for treating centrally mediated nausea and vomiting |
| 02/10/2015 | US8951965 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 02/10/2015 | US8951636 Composite particles which contain both cellulose and inorganic compound |
| 02/10/2015 | US8951578 Rebound hoof pack |
| 02/10/2015 | US8951571 Polymer vesicles for selective electromagnetic energy-induced delivery |
| 02/10/2015 | US8951570 Manufacture of multiple minicapsules |
| 02/10/2015 | US8951569 Pellets coated with coatings containing active substances |
| 02/10/2015 | US8951568 Granule and preparation method thereof |
| 02/10/2015 | US8951567 Sol-gel phase-reversible hydrogel templates and uses thereof |
| 02/10/2015 | US8951566 Process for preparing products comprising stabilised actives and compositions comprising same |
| 02/10/2015 | US8951565 Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as chitosan |
| 02/10/2015 | US8951564 Galenic form suitable for absorbing, in a specific manner, the undesirable molecules in the digestive tract |
| 02/10/2015 | US8951563 Antibiotic drug delivery and potentiation |
| 02/10/2015 | US8951562 Method and apparatus or dry granulation |
| 02/10/2015 | US8951561 Methods and systems for treating cell proliferation disorders using plasmonics enhanced photospectral therapy (PEPST) and exciton-plasmon enhanced phototherapy (EPEP) |
| 02/10/2015 | US8951560 Isoflavone nanoparticles and use thereof |
| 02/10/2015 | US8951559 Nano-structured thixotropic inorganic peeling gels |
| 02/10/2015 | US8951558 Aqueous carbonated medium containing an amino(meth)acrylate polymer or copolymer |
| 02/10/2015 | US8951557 Sustained release solid formulations and methods of manufacturing the same |
| 02/10/2015 | US8951556 Oral drug delivery system |
| 02/10/2015 | US8951555 Controlled release hydrocodone formulations |
| 02/10/2015 | US8951554 Microcapsule, structure having a microcapsule, article having a microcapsule, and method of preparing microcapsules |
| 02/10/2015 | US8951553 Composition for promoting vascular smooth muscle relaxation |
| 02/10/2015 | US8951552 In situ film-forming bioactive solutions of absorbable multiblock copolymers |
| 02/10/2015 | US8951551 Multiribbon nanocellulose as a matrix for wound healing |
| 02/10/2015 | US8951548 Acrylic hydrogels with pendant cyclodextrins, preparation method thereof and use of same as release systems and contact lens components |
| 02/10/2015 | US8951547 Drug delivery system |
| 02/10/2015 | US8951545 Insertable medical devices having microparticulate-associated elastic substrates and methods for drug delivery |
| 02/10/2015 | US8951542 Lipid vesicle compositions and methods of use |
| 02/10/2015 | US8951541 Method of modifying dissolution rate of particles by addition of hydrophobic nanoparticles |
| 02/10/2015 | US8951540 Biomimetic hydroxyapatite synthesis |
| 02/10/2015 | US8951539 Methods of promoting angiogenesis using cerium oxide nanoparticles |
| 02/10/2015 | US8951519 Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins |
| 02/10/2015 | US8951504 (trimethoxyphenylamino) pyrimidinyl formulations |
| 02/10/2015 | US8951450 Apparatus and method for production of liposomes |
| 02/10/2015 | US8951234 Pharmaceutical dosages delivery system |
| 02/10/2015 | US8950394 Preservative-free single dose inhaler systems |
| 02/10/2015 | CA2744008C Coating material for solid medicine and solid medicine formed with the same |
| 02/10/2015 | CA2672134C Solid medicinal preparation containing mannitol or lactose |
| 02/10/2015 | CA2671670C Sustained-release composition and method for producing the same |
| 02/10/2015 | CA2643330C Crush-resistant oxycodone tablets intended for preventing accidental misuse and unlawful diversion |
| 02/10/2015 | CA2633878C Water-soluble films comprising low-viscosity alginates |
| 02/10/2015 | CA2633599C Use of film-forming hair-care polymers from the group of polyurethanes and pharmaceutical preparations and plasters containing said polymers |
| 02/10/2015 | CA2607802C Pharmaceutical formulation of apomorphine for buccal administration |
| 02/10/2015 | CA2586553C Nasal sprayer containing a formulation with olopatadine |
| 02/10/2015 | CA2523363C Compositions, targets, methods and devices for the therapy of ocular and periocular disorders |
| 02/05/2015 | WO2015017854A1 Method to functionalize cells in human blood, other fluids and tissues using nanoparticles |
| 02/05/2015 | WO2015017807A1 Liposomal formulations for the treatment of bacterial infections |
| 02/05/2015 | WO2015017784A1 Tissue engineered models of cancers |